Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALIMTA Plus Cisplatin in Advanced Gastric Carcinoma
NCT00190801Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Sep 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pemetrexed in Gastric carcinoma (GC), sponsored by Eli Lilly and Company. Started Sep 2003; status: completed.
02
Drugs
pemetrexed
03
Conditions
Gastric carcinoma (GC)
Beyond the preview
Go deeper on NCT00190801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00190801.